Total Payments
$4,235
2024 Payments
$373.18
Companies
6
Transactions
10
Medicare Patients
1,618
Medicare Billing
$217,582
Payment Breakdown by Category
Consulting$2,498 (59.0%)
Other$1,250 (29.5%)
Research$330.00 (7.8%)
Education$95.60 (2.3%)
Food & Beverage$61.87 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,498 | 1 | 59.0% |
| Honoraria | $1,250 | 1 | 29.5% |
| Unspecified | $330.00 | 1 | 7.8% |
| Education | $95.60 | 5 | 2.3% |
| Food and Beverage | $61.87 | 2 | 1.5% |
Payments by Type
General
$3,905
9 transactions
Research
$330.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,523 | 2 | $0 (2024) |
| PFIZER INC. | $1,592 | 3 | $0 (2024) |
| Gilead Sciences, Inc. | $56.56 | 2 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.93 | 1 | $0 (2022) |
| Immunocore Limited | $17.23 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $16.14 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $373.18 | 3 | PFIZER INC. ($330.00) |
| 2023 | $44.64 | 1 | Gilead Sciences, Inc. ($44.64) |
| 2022 | $29.93 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($29.93) |
| 2021 | $3,759 | 3 | AstraZeneca Pharmaceuticals LP ($2,498) |
| 2020 | $16.14 | 1 | E.R. Squibb & Sons, L.L.C. ($16.14) |
| 2017 | $11.66 | 1 | PFIZER INC. ($11.66) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Education | In-kind items and services | $25.95 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Immunocore Limited | KIMMTRAK (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Oncology | ||||||
| 07/09/2024 | PFIZER INC. | — | — | In-kind items and services | $330.00 | Research |
| Study: PF06647263 CLINICAL PUBLICATION PROGRAM | ||||||
| 12/08/2023 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $44.64 | General |
| Category: ONC | ||||||
| 03/10/2022 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Education | In-kind items and services | $29.93 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2021 | PFIZER INC. | TALZENNA (Drug) | Honoraria | Cash or cash equivalent | $1,250.00 | General |
| Category: ONCOLOGY | ||||||
| 10/27/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $2,497.50 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 07/13/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $16.14 | General |
| Category: Oncology | ||||||
| 07/11/2017 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $11.66 | General |
| Category: ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PF06647263 CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $330.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 353 | 618 | $120,206 | $44,789 |
| 2022 | 9 | 445 | 796 | $152,517 | $57,519 |
| 2021 | 9 | 469 | 835 | $156,963 | $66,278 |
| 2020 | 8 | 351 | 691 | $133,048 | $48,997 |
Total Patients
1,618
Total Services
2,940
Medicare Billing
$217,582
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 119 | 265 | $47,700 | $16,652 | 34.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 146 | $26,280 | $9,742 | 37.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 32 | 54 | $12,960 | $5,163 | 39.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 40 | $9,600 | $4,040 | 42.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 26 | $9,178 | $3,270 | 35.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $4,560 | $1,812 | 39.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 20 | $3,640 | $1,658 | 45.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 24 | $3,048 | $1,312 | 43.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 22 | 24 | $3,240 | $1,140 | 35.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 139 | 363 | $64,269 | $23,433 | 36.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 138 | $24,427 | $8,842 | 36.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 34 | 52 | $12,300 | $5,501 | 44.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 48 | 50 | $11,944 | $4,409 | 36.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 54 | $9,828 | $3,946 | 40.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 19 | 19 | $6,361 | $2,619 | 41.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 24 | $5,679 | $2,546 | 44.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 16 | $5,648 | $2,389 | 42.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 26 | $3,302 | $1,318 | 39.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 13 | 13 | $3,480 | $1,057 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 22 | 22 | $2,826 | $761.31 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 19 | $2,453 | $698.01 | 28.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 145 | 416 | $71,968 | $29,508 | 41.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 39 | 61 | $14,091 | $6,951 | 49.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 66 | 66 | $15,708 | $6,753 | 43.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 72 | $12,456 | $5,558 | 44.6% |
About Dr. Brooke Holbrook, M.D
Dr. Brooke Holbrook, M.D is a Internal Medicine healthcare provider based in Edgewood, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1407050065.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brooke Holbrook, M.D has received a total of $4,235 in payments from pharmaceutical and medical device companies, with $373.18 received in 2024. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($2,498).
As a Medicare-enrolled provider, Holbrook has provided services to 1,618 Medicare beneficiaries, totaling 2,940 services with total Medicare billing of $217,582. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Edgewood, KY
- Active Since 06/14/2007
- Last Updated 03/26/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1407050065
Products in Payments
- LYNPARZA (Drug) $2,498
- TALZENNA (Drug) $1,250
- Trodelvy (Drug) $44.64
- NINLARO (Drug) $29.93
- ENHERTU (Biological) $25.95
- KIMMTRAK (Drug) $17.23
- OPDIVO (Biological) $16.14
- INLYTA (Drug) $11.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Edgewood
Dr. Minsig Choi, Md, MD
Internal Medicine — Payments: $695,448
Internal Medicine $695,448
Farzin Foruhari, Md, MD
Internal Medicine — Payments: $15,628
Internal Medicine $15,628
Robert Wagner, Md, MD
Internal Medicine — Payments: $11,988
Internal Medicine $11,988
Dr. Amaninderapal Ghotra, Md, MD
Internal Medicine — Payments: $8,962
Internal Medicine $8,962
Keerthy Narisetty, M.d, M.D
Internal Medicine — Payments: $8,244
Internal Medicine $8,244
Dr. Sulsal Ul Haque, M.d, M.D
Internal Medicine — Payments: $6,526
Internal Medicine $6,526